Viewing Study NCT02034734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2026-02-20 @ 3:44 PM
Study NCT ID: NCT02034734
Status: COMPLETED
Last Update Posted: 2014-01-13
First Post: 2014-01-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male Subjects
Sponsor: Astellas Pharma Europe B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetics of ASP3652 View
None Pharmacodynamics of ASP3652 View
None Healthy Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None ASP3652 View
None Cerebrospinal fluid (CSF) View
None Multiple doses View